MarketHealth CareLife Sciences Tools & ServicesLife Sciences Tools & Services
ARCH BIOPARTNERS INC

ACHFF

$0.34Apr 26, 2021Apr 24, 2026
Health CareLife Sciences Tools & Services$27M
MVM
-$0.7M
TD Variance
-3.010

Every news event mapped to its market reaction — 17 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-03-30-18.2%newsMT NewswiresArch Biopartners Arranges Non-Brokered Private Placement
2026-03-30-18.2%newsGlobeNewswireArch Biopartners Arranges Non-Brokered Private Placement - GlobeNewswire
2026-02-10+13.6%newsStreetwise ReportsTechnically Oversold with Support Solid Patents & A Heavyweight Board: Is This Stock Set to Soar? - Streetwise Reports
2026-02-09+11.2%newsGlobeNewswireArch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
2026-03-24-11.1%expansionGlobeNewswireArch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
2026-03-24-11.1%newsStock TitanA 9th hospital joins Arch’s study to prevent kidney injury after heart surgery - Stock Titan
2026-03-20-5.4%newsMT NewswiresArch Biopartners Says Toronto's St Mike's Hospital Begins Patient Dosing In Phase II LSALT Peptide Trial
2026-03-20-5.4%newsGlobeNewswireArch Biopartners Announces St. Michael’s Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide
2025-04-22-5.0%newsStock TitanMajor Breakthrough: Toronto General Hospital Joins Phase II Kidney Injury Prevention Trial - 7th Global Site Added - Stock Titan
2025-03-05+4.7%newsSeeking AlphaArch Biopartners arranges non-brokered private placement
2025-11-06+2.3%M&AKalkine MediaArch Biopartners (TSXV:ARCH) Advances CS-AKI Trial and Completes Lipdro Acquisition - Kalkine Media
2026-04-02-2.3%newsMT NewswiresArch Biopartners Raises $600,000 in Private Placement of Shares
2026-04-02-2.3%newsGlobeNewswireArch Biopartners Closes Non-Brokered Private Placement
2025-04-24-0.8%newsStock TitanACHFF Stock Price, News & Analysis - Stock Titan
2025-04-24-0.8%newsStock TitanNRXBF Stock Price, News & Analysis - Stock Titan
2024-07-29-0.7%newsSeeking AlphaArch Biopartners arranges non-brokered private placement
2025-11-10+0.4%expansionSeeking AlphaArch biopartners launches non-brokered private placement
tickerdossier.comtickerdossier.substack.com